Companion Diagnostics Market is Likely to witness profitable growth Over the Next Five Years

Launching announcement of a new research report on Companion Diagnostics Market:  By Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, and Infectious Diseases), Technology (PCR, IHC, NGS, and ISH) By Testing Facility (Hospital Laboratories, Independent Clinical Laboratories and Others), by Region (North America, Western Europe, Asia-Pacific, Latin America, Rest of the World).
This report, from Stratview Research, studies the global clinical diagnostics market - companion diagnostics over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
 
Click here to read the detailed description and TOC:
https://www.stratviewresearch.com/409/companion-diagnostics-market.html
 
The Global Clinical Diagnostics Market – Companion Diagnostics: Highlights
Companion diagnostics are considered as one of the most important tools for the implementation of personalized medicine. This enables the physician in identifying a specific biomarker that could indicate the patients most likely outcome-based combination of therapies or even specific treatment regimen.
 
InVentiv Health's survey (2017 by Jessica Lee, Ravi Patel, David Ruch and Katya Magonova) with practicing oncologists in the US predicted that 90% of the participating physician (n=30 out of total pool of 85) might accept a multi-biomarker diagnostic tool as the standard of care in the next three to five years. Can the results from 30 oncologists predict an accurate demand trend in the US market? But what about the other regions? What will be the adoption rate in the EU5, major markets such as China, Korea, Japan, Singapore and Australia?
Get your copy of free sample pages-click here: https://www.stratviewresearch.com/Request-Sample/409/companion-diagnostics-market.html
 
Companion diagnostics that can help identify the right patient for the right drug at the right time are playing a major role in this trend. Companies like Astellas, Takeda, Astra Zeneca are making in-roads in this market. This report will help the reader look at the market from 360-degree view, while the in-depth demand analysis will help the manufacturer prioritize the right segment, the hurdles and issues faced by the manufacturers will also help the policy makers realize where to cap the price and where all to subsidize. The comprehensive study will encompass the demand and supply side of the market to help the reader get a complete top down approach of the companion diagnostic market.
 
Report Features
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

• Market structure: Overview, industry life cycle analysis, supply chain analysis
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
• Market trend and forecast analysis
• Market segment trend and forecast
• Competitive landscape and dynamics: Market share, Product portfolio, New product launches, etc.
• Attractive market segments and associated growth opportunities
• Emerging trends
• Strategic growth opportunities for the existing and new players
• Key success factors
• Future outlook

 
To browse through our range of reports in the Healthcare and Life Science industry, refer to the following link:
https://www.stratviewresearch.com/market-reports/Healthcare-and-Life-Sciences.html